Location: New York, NY
CIK: 0001727492 · Show all filings
Period: Q1 2026 (← Previous)
Filing Date: May 15, 2026
Total Value: $1.503B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| CGON | CG ONCOLOGY INC | 900,000 | $60.91M | 4.1% | — | — | CALL | 156944100 |
| SYRE | SPYRE THERAPEUTICS INC | 878,127 | $44.29M | 2.9% | $34.53 | 0.0% | COM NEW | 00773J202 |
| LBRX | LB PHARMACEUTICALS INC | 1,438,070 | $34.63M | 2.3% | $22.38 | 0.0% | COM SHS | 50180M108 |
| SABS | SAB BIOTHERAPEUTICS INC | 7,967,207 | $30.51M | 2.0% | $4.00 | 0.0% | COM NEW | 78397T202 |
| IRD | OPUS GENETICS INC | 6,075,028 | $27.64M | 1.8% | $2.74 | 0.0% | COM | 67577R102 |
| MBX | MBX BIOSCIENCES INC | 848,590 | $25.33M | 1.7% | $36.83 | 0.0% | COM | 55287L101 |
| RVMD | REVOLUTION MEDICINES INC | 228,900 | $22.26M | 1.5% | $57.25 | +80.0% | CALL | 76155X100 |
| SNSE | SENSEI BIOTHERAPEUTICS INC | 126,002 | $3.972M | 0.3% | $13.96 | 0.0% | COM NEW | 81728A207 |
| ADMA | ADMA BIOLOGICS INC | 300,000 | $2.703M | 0.2% | $17.05 | -0.6% | CALL | 000899104 |
| AURA | AURA BIOSCIENCES INC | 229,864 | $1.538M | 0.1% | $5.44 | 0.0% | COM | 05153U107 |
| XLO | XILIO THERAPEUTICS INC | 112,128 | $943K | 0.1% | $8.41 | — | COM | 98422T209 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| RVMD | REVOLUTION MEDICINES INC | 1,652,808 (+28.7%) | $161M (+57.2%) | 10.7% | $57.25 | +80.0% | COM | 76155X100 |
| XENE | XENON PHARMACEUTICALS INC | 1,393,027 (+153.4%) | $81M (+228.8%) | 5.4% | $39.83 | +5.4% | COM | 98420N105 |
| PCVX | VAXCYTE INC | 2,060,719 (+20.9%) | $120M (+52.2%) | 8.0% | $46.11 | +14.4% | COM | 92243G108 |
| VOR | VOR BIOPHARMA INC | 1,925,066 (+108.1%) | $34.34M (+244.7%) | 2.3% | $16.21 | -13.7% | COM NEW | 929033207 |
| TYRA | TYRA BIOSCIENCES INC | 1,276,968 (+35.2%) | $48.91M (+97.0%) | 3.3% | $17.45 | +73.4% | COM | 90240B106 |
| IVA | INVENTIVA SA | 4,974,906 (+148.7%) | $27.61M (+196.9%) | 1.8% | $5.19 | — | ADS | 46124U107 |
| ADMA | ADMA BIOLOGICS INC | 4,756,511 (+57.9%) | $42.86M (-22.0%) | 2.9% | $17.05 | -0.6% | COM | 000899104 |
| AVTX | AVALO THERAPEUTICS INC | 1,635,023 (+85.5%) | $24.41M (+52.5%) | 1.6% | $12.02 | +28.9% | COM NEW | 05338F306 |
| MAZE | MAZE THERAPEUTICS INC | 614,962 (+11.8%) | $18.36M (-19.5%) | 1.2% | $35.39 | +24.4% | COM | 578784100 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| MLYS | MINERALYS THERAPEUTICS INC | 2,298,400 | $83.41M | 5.6% | $14.60 | +114.8% | PUT | 603170101 |
| INBX | INHIBRX BIOSCIENCES INC | 323,565 | $25.56M | 1.7% | $36.34 | +113.9% | — | 45720N103 |
| XENE | XENON PHARMACEUTICALS INC | 549,700 | $24.64M | 1.6% | $39.83 | +5.4% | PUT | 98420N105 |
| RAPT | RAPT THERAPEUTICS INC | 644,400 | $21.83M | 1.5% | $31.06 | +62.6% | — | 75382E208 |
| INBX | INHIBRX BIOSCIENCES INC | 150,000 | $11.85M | 0.8% | $36.34 | +113.9% | CALL | 45720N103 |
| SPRB | SPRUCE BIOSCIENCES INC | 20,514 | $1.787M | 0.1% | $107.14 | -30.4% | — | 85209E208 |
| ELDN | ELEDON PHARMACEUTICALS INC | 555,978 | $840K | 0.1% | $2.38 | -12.3% | — | 28617K101 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| TNGX | TANGO THERAPEUTICS INC | 2,408,798 (-35.4%) | $50.39M (+52.5%) | 3.4% | $8.62 | +38.2% | COM | 87583X109 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ABVX | ABIVAX SA | 1,461,924 | $163M | 10.8% | $7.07 | — | SPONSORED ADS | 00370M103 |
| LQDA | LIQUIDIA CORPORATION | 8,118,892 | $306M | 20.4% | $5.57 | +580.7% | COM NEW | 53635D202 |
| MLYS | MINERALYS THERAPEUTICS INC | 2,772,654 | $75.11M | 5.0% | $14.60 | +114.8% | COM | 603170101 |
| ANIK | ANIKA THERAPEUTICS INC | 1,435,130 | $20.81M | 1.4% | $25.57 | -61.4% | COM | 035255108 |
| VRCA | VERRICA PHARMACEUTICALS INC | 923,910 | $4.887M | 0.3% | $6.03 | +16.4% | COM SHS | 92511W207 |
| EXEL | EXELIXIS INC | 1,553,262 | $66.62M | 4.4% | $19.81 | +121.0% | COM | 30161Q104 |
| AGIO | AGIOS PHARMACEUTICALS INC | 90,000 | $3.045M | 0.2% | — | — | CALL | 00847X104 |